Cargando…

From the Gut to the Lung: Evidence of Antifibrotic Activity of Endocrine Fibroblast Growth Factor 19

Detalles Bibliográficos
Autores principales:	Guzy, Robert D., Bollenbecker, Seth, Krick, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348557/ https://www.ncbi.nlm.nih.gov/pubmed/35580176 http://dx.doi.org/10.1165/rcmb.2022-0057ED

Ejemplares similares

Fibroblast Growth Factor Signaling in Development and Disease
por: Bollenbecker, Seth, et al.
Publicado: (2023)

Fibroblast Growth Factor Inhibitors in Lung Fibrosis: Friends or Foes?
por: Guzy, Robert
Publicado: (2020)

Fibroblast Growth Factor 23 Signaling Does Not Increase Inflammation from Pseudomonas aeruginosa Infection in the Cystic Fibrosis Bronchial Epithelium
por: Hirsch, Meghan June, et al.
Publicado: (2023)

Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease
por: Easter, Molly, et al.
Publicado: (2020)

429 Elevated Phosphate Levels Induce Lung Inflammation and Exacerbate Pulmonary Fibrosis
por: Bollenbecker, Seth, et al.
Publicado: (2022)

Antifibrotic in interstitial lung diseases: When, where, and how long?
por: Rai, Deependra K., et al.
Publicado: (2022)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

RNA Sequencing Uncovers Antifibrotic Genes during Lung Fibrosis Resolution
por: Han, Hongwei, et al.
Publicado: (2021)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

“Yap”-ing about the Antifibrotic Benefits of Prostacyclin
por: Huang, Steven K.
Publicado: (2019)

The Gut Microbiota Regulates Endocrine Vitamin D Metabolism through Fibroblast Growth Factor 23
por: Bora, Stephanie A., et al.
Publicado: (2018)

Endocrine Fibroblast Growth Factors in Relation to Stress Signaling
por: Shimizu, Makoto, et al.
Publicado: (2022)

Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation
por: Vu, Tuong N., et al.
Publicado: (2019)

Phosphatidylethanolamine Induces an Antifibrotic Phenotype in Normal Human Lung Fibroblasts and Ameliorates Bleomycin-Induced Lung Fibrosis in Mice
por: Vazquez-de-Lara, Luis G., et al.
Publicado: (2018)

Fibroblast Growth Factor Receptor 4 Deficiency Mediates Airway Inflammation in the Adult Healthy Lung?
por: Easter, Molly, et al.
Publicado: (2020)

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
por: Murray, Lynne A., et al.
Publicado: (2017)

The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects
por: Bogatkevich, Galina S., et al.
Publicado: (2012)

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
por: Song, Yinghua, et al.
Publicado: (2013)

Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
por: Hadda, Vijay, et al.
Publicado: (2020)

Targeting fibroblast growth factors in cancer
por: Baker, Kevin P., et al.
Publicado: (2013)

B Cells in Idiopathic Pulmonary Fibrosis: Targeting Immune Cells with Antifibrotic Agents
por: Roman, Jesse, et al.
Publicado: (2021)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Antifibrotic effect by activation of peroxisome proliferator-activated receptor–γ in corneal fibroblasts
por: Pan, Hongwei, et al.
Publicado: (2009)

The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro
por: Stougaard, Julie, et al.
Publicado: (2018)

Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts
por: Peterson, Joshua M., et al.
Publicado: (2022)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020)

Broad Adoption of Antifibrotics in Idiopathic Pulmonary Fibrosis: Still a Long Way to Go
por: Assayag, Deborah
Publicado: (2021)

Kindlin for the Fire: Targeting Proline Synthesis to Extinguish Matrix Production in Pulmonary Fibrosis
por: Guzy, Robert, et al.
Publicado: (2021)

Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts
por: Park, Sung Joon, et al.
Publicado: (2021)

Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts
por: Tsoyi, Konstantin, et al.
Publicado: (2022)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model
por: Higuchi, Tomoaki, et al.
Publicado: (2023)

Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23
por: Leifheit-Nestler, Maren, et al.
Publicado: (2018)

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2021)

Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Seifirad, Soroush, et al.
Publicado: (2021)

Analyses of the Efficacy and Safety of Antifibrotic Therapies in Non-IPF Pulmonary Fibrosis, Progressing Despite Management
por: Wells, Athol U.
Publicado: (2022)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease
por: Krick, Stefanie, et al.
Publicado: (2021)

Phosphate induces inflammation and exacerbates injury from cigarette smoke in the bronchial epithelium
por: Bollenbecker, Seth, et al.
Publicado: (2023)

Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1
por: BUJOR, ANDREEA M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0451g5e3givd1dg0l7ljniogr7